Cite
HARVARD Citation
Ayrignac, X. et al. (2019). Assessing the risk of multiple sclerosis disease-modifying therapies. Expert review of neurotherapeutics. pp. 695-706. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ayrignac, X. et al. (2019). Assessing the risk of multiple sclerosis disease-modifying therapies. Expert review of neurotherapeutics. pp. 695-706. [Online].